This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Harrisonia abyssinica is a medicinal plant used in traditional medicine across East and West Africa, demonstrating in vitro antibacterial, antifungal, and antiplasmodial activities [PMID:23196018, 19653145, 34867053].
Background
Harrisonia abyssinica is a plant species utilized in traditional healthcare practices in regions including Kenya, Tanzania, Uganda, and Guinea [PMID:35368751, 34867053, 19171185, 17825510].
Traditional uses
It is used as traditional medicine in Tanzania [PMID:34867053] and in Uganda for ethnoveterinary purposes to treat livestock diseases [PMID:19171185]. It is also used in Kenya for the management of bacterial infections [PMID:35368751].
Active compounds
Isolated compounds include steroids such as beta-sitosterol, stigmasterol, campesterol, beta-sitostenone, stigmastenone, campestenone, stigmasta-3,5-dien-7-one, stigmasta-3,5,22-trien-7-one, and campesta-3,5-dien-7-one [PMID:10705738]; limonoids including deoxyobacunone, obacunone, harrisonin, 12beta-acetoxyharrisonin, and pedonin [PMID:11720527]; prenylated acetophenones harronin I and harronin II [PMID:22234410]; tannins chebulagic acid and chebulanin [PMID:25001554]; a cycloterpene called cycloabyssinone and 3-friedelanone [PMID:11395274]; and prenylated polyketides oumarone, bissaone, and aissatone [PMID:10075789].
Mechanism of action
Chebulagic acid and chebulanin isolated from the plant specifically inhibit the calcineurin pathway in Cryptococcus neoformans [PMID:25001554]. Leaf extracts have been shown to modulate neurobehavioral, biochemical, and histopathological activities in aluminum-induced Alzheimer's disease models by affecting hippocampal monoamine and glutamate levels, Bcl2 expression, and inflammatory markers (TNF-α, IL-1β) [PMID:34208063].
Clinical evidence
Evidence DBacterial Infections
Extracts inhibited growth of Staphylococcus aureus, Enterococcus faecium, and Streptococcus uberis (MIC < 1 mg/mL) [PMID:34867053]. Other studies showed activity against Gram-positive and Gram-negative bacteria, though some root extracts showed MIC values ≥ 8 mg/ml [PMID:19057813, 9533435].
Evidence DFungal Infections
Extracts exhibited in vitro antifungal activity [PMID:23196018]; specifically, harronin I showed a MIC of 5 μg/mL against Candida albicans [PMID:22234410] and tannins chebulagic acid and chebulanin showed potent activity against human pathogenic fungi [PMID:25001554].
Leaf extract ameliorated neurobehavioral, histological, and biochemical changes in the hippocampus of rats with aluminum chloride-induced Alzheimer's disease [PMID:34208063].
Evidence DSchistosomiasis (Animal Model)
An ethanol extract of H. abyssinica proved to be inactive against Schistosoma mansoni in mice [PMID:2497476].
Drug interactions
Ethanolic extracts of Harrisonia abyssinica inhibited the activity of human cytochrome P450 3A subfamily enzymes (CYP3A4, CYP3A5, and CYP3A7) by more than 90% in vitro [PMID:20109542].
Evidence summary
The current evidence consists primarily of in vitro studies and animal models (Level D), demonstrating broad antimicrobial and neuroprotective potential, but lacks human clinical trials.
PubMed sources
1.PMID: 35368751 (2022) — A Systematic Review of Medicinal Plants of Kenya used in the Management of Bacterial Infections. · Evidence-based complementary and alternative medicine : eCAM
3.PMID: 23196018 (1995) — Biological investigations on Harrisonia abyssinica. · Phytomedicine : international journal of phytotherapy and phytopharmacology
4.PMID: 34208063 (2021) — A Leaf Extract of Harrisonia abyssinica Ameliorates Neurobehavioral, Histological and Biochemical Changes in the Hippocampus of Rats with Aluminum Chloride-Induced Alzheimer's Disease. · Antioxidants (Basel, Switzerland)
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
— Antimicrobial activities and phytochemical analysis of Harrisonia abyssinica (Oliv) and Vepris simplicifolia (Verd) extracts used as traditional medicine in Tanzania.
· Saudi journal of biological sciences
6.PMID: 22234410 (2012) — Antimicrobial prenylated acetophenones from berries of Harrisonia abyssinica. · Planta medica
7.PMID: 9533435 (1998) — Antibacterial activity of East African medicinal plants. · Journal of ethnopharmacology
8.PMID: 19171185 (2009) — Ethnoveterinary knowledge in pastoral Karamoja, Uganda. · Journal of ethnopharmacology
9.PMID: 11720527 (2001) — Limonoids from Nigerian Harrisonia abyssinica and their stimulatory activity against Striga hermonthica seeds. · Journal of natural products
10.PMID: 2497476 (1989) — Schistosomicidal effects of Pavetta owariensis and Harrisonia abyssinica in mice infected with Schistosoma mansoni. · Planta medica
11.PMID: 25001554 (2014) — Inhibition of the calcineurin pathway by two tannins, chebulagic acid and chebulanin, isolated from Harrisonia abyssinica Oliv. · Journal of microbiology and biotechnology
12.PMID: 11395274 (2001) — Cycloabyssinone, a new cycloterpene from Harrisonia abyssinica. · Fitoterapia
13.PMID: 32071543 (2020) — Antivenin plants used for treatment of snakebites in Uganda: ethnobotanical reports and pharmacological evidences. · Tropical medicine and health
14.PMID: 19057813 (2008) — Antibacterial and cytotoxic activity of Kenyan medicinal plants. · Memorias do Instituto Oswaldo Cruz
15.PMID: 10075789 (1999) — Oumarone, bissaone, and aissatone, unusual prenylated polyketides from harrisonia abyssinica. · Journal of natural products
16.PMID: 20161933 (2008) — Multi-plant or single-plant extracts, which is the most effective for local healing in Tanzania? · African journal of traditional, complementary, and alternative medicines : AJTCAM
17.PMID: 8874968 (1996) — Activity of east African medicinal plants against Helicobacter pylori. · Chemotherapy
18.PMID: 8786762 (1996) — Fungistatic and fungicidal activity of east African medicinal plants. · Mycoses
19.PMID: 19653145 (2010) — Screening of Tanzanian medicinal plants against Plasmodium falciparum and human immunodeficiency virus. · Planta medica
20.PMID: 17825510 (2007) — Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine. · Journal of ethnopharmacology
21.PMID: 19548257 (2010) — Screening of some Kenyan medicinal plants for antibacterial activity. · Phytotherapy research : PTR
22.PMID: 18274285 (2007) — Limonoids as larvicidal components against mosquito larvae (Aedes aegypti Linn.). · Zeitschrift fur Naturforschung. C, Journal of biosciences
23.PMID: 20109542 (2010) — In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily. · Journal of ethnopharmacology
24.PMID: 10363837 (1999) — Antiplasmodial activity of selected Sudanese medicinal plants with emphasis on Maytenus senegalensis (Lam.) Exell. · Journal of ethnopharmacology
25.PMID: 25932373 (2015) — Characterization of the goat feeding system among rural small holder farmers in the semi-arid regions of Uganda. · SpringerPlus